The Executive Board anticipates an adjusted EBITDA of around €2.4 billion for 2015, with sales of around €13.5 billion.
“It is already clear that we ended the past fiscal year successfully,” said Klaus Engel, chairman of the Executive Board. “We would like our shareholders to participate in that. Our intention of raising the dividend is also coupled with confidence that we can shape the new fiscal year successfully.”
Evonik has increased the dividend by an average of 9% per year over the past six years.